Roxana G Burciu1, Jae Woo Chung1, Priyank Shukla1, Edward Ofori1, Hong Li1, Nikolaus R McFarland1, Michael S Okun1, David E Vaillancourt2. 1. From the Department of Applied Physiology and Kinesiology (R.G.B., J.W.C., P.S., E.O., D.E.V.) and the Departments of Neurology (N.R.M., M.S.O., D.E.V.) and Neurosurgery (M.S.O.), Center for Movement Disorders and Neurorestoration, and Department of Biomedical Engineering (D.E.V.), University of Florida, Gainesville; and Department of Public Health Sciences (H.L.), Medical University of South Carolina, Charleston. 2. From the Department of Applied Physiology and Kinesiology (R.G.B., J.W.C., P.S., E.O., D.E.V.) and the Departments of Neurology (N.R.M., M.S.O., D.E.V.) and Neurosurgery (M.S.O.), Center for Movement Disorders and Neurorestoration, and Department of Biomedical Engineering (D.E.V.), University of Florida, Gainesville; and Department of Public Health Sciences (H.L.), Medical University of South Carolina, Charleston. vcourt@ufl.edu.
Abstract
OBJECTIVE: To explore longitudinal changes in brain activity in patients with Parkinson disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) using task-based functional MRI (fMRI). METHODS: A total of 112 individuals were scanned 1 year apart while performing a unimanual grip force task: 46 PD, 13 MSA, 19 PSP, and 34 healthy controls. The outcome measure was percent signal change in prespecified regions of interest: putamen, primary motor cortex (M1), supplementary motor area (SMA), and superior motor regions of the cerebellum (lobules V-VI). RESULTS: Patients with PD showed a decline in functional activity over the course of 1 year in the putamen and M1 compared to controls. Changes after 1 year in MSA were exclusively extrastriatal, and included a reduction in functional activity in M1, SMA, and superior cerebellum. In PSP, all regions of interest were less active at 1 year compared to baseline. The functional activity of these regions did not change in the control group. CONCLUSIONS: We provide evidence using task-based fMRI for cortical and striatal functional deterioration in PD over a 1-year period of time. Results also describe more widespread and unique patterns of functional changes in MSA and PSP compared to PD, suggesting distinct rates of disease progression in parkinsonian disorders that may assist in future clinical studies testing the potential efficacy of disease-modifying therapies.
OBJECTIVE: To explore longitudinal changes in brain activity in patients with Parkinson disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) using task-based functional MRI (fMRI). METHODS: A total of 112 individuals were scanned 1 year apart while performing a unimanual grip force task: 46 PD, 13 MSA, 19 PSP, and 34 healthy controls. The outcome measure was percent signal change in prespecified regions of interest: putamen, primary motor cortex (M1), supplementary motor area (SMA), and superior motor regions of the cerebellum (lobules V-VI). RESULTS: Patients with PD showed a decline in functional activity over the course of 1 year in the putamen and M1 compared to controls. Changes after 1 year in MSA were exclusively extrastriatal, and included a reduction in functional activity in M1, SMA, and superior cerebellum. In PSP, all regions of interest were less active at 1 year compared to baseline. The functional activity of these regions did not change in the control group. CONCLUSIONS: We provide evidence using task-based fMRI for cortical and striatal functional deterioration in PD over a 1-year period of time. Results also describe more widespread and unique patterns of functional changes in MSA and PSP compared to PD, suggesting distinct rates of disease progression in parkinsonian disorders that may assist in future clinical studies testing the potential efficacy of disease-modifying therapies.
Authors: Janey Prodoehl; Peggy J Planetta; Ajay S Kurani; Cynthia L Comella; Daniel M Corcos; David E Vaillancourt Journal: JAMA Neurol Date: 2013-01 Impact factor: 18.302
Authors: Peggy J Planetta; Edward Ofori; Ofer Pasternak; Roxana G Burciu; Priyank Shukla; Jesse C DeSimone; Michael S Okun; Nikolaus R McFarland; David E Vaillancourt Journal: Brain Date: 2015-12-24 Impact factor: 13.501
Authors: S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet Journal: Neurology Date: 2008-08-26 Impact factor: 9.910
Authors: Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger Journal: Lancet Neurol Date: 2017-06-13 Impact factor: 44.182
Authors: Roxana G Burciu; Christopher W Hess; Stephen A Coombes; Edward Ofori; Priyank Shukla; Jae Woo Chung; Nikolaus R McFarland; Aparna Wagle Shukla; Michael S Okun; David E Vaillancourt Journal: Hum Brain Mapp Date: 2017-06-08 Impact factor: 5.038
Authors: Qiaoling Zeng; Xiaojun Guan; Jason C F Law Yan Lun; Zhujing Shen; Tao Guo; Min Xuan; Quanquan Gu; Xiaojun Xu; Min Chen; Minming Zhang Journal: Neurosci Bull Date: 2017-08-21 Impact factor: 5.203
Authors: Roxana G Burciu; Rachael D Seidler; Priyank Shukla; Mike A Nalls; Andrew B Singleton; Michael S Okun; David E Vaillancourt Journal: Neurobiol Aging Date: 2018-02-10 Impact factor: 4.673
Authors: Katrina Gwinn; Karen K David; Christine Swanson-Fischer; Roger Albin; Coryse St Hillaire-Clarke; Beth-Anne Sieber; Codrin Lungu; F DuBois Bowman; Roy N Alcalay; Debra Babcock; Ted M Dawson; Richard B Dewey; Tatiana Foroud; Dwight German; Xuemei Huang; Vlad Petyuk; Judith A Potashkin; Rachel Saunders-Pullman; Margaret Sutherland; David R Walt; Andrew B West; Jing Zhang; Alice Chen-Plotkin; Clemens R Scherzer; David E Vaillancourt; Liana S Rosenthal Journal: Biomark Med Date: 2017-06-23 Impact factor: 2.851
Authors: Antonio P Strafella; Nico I Bohnen; Nicola Pavese; David E Vaillancourt; Thilo van Eimeren; Marios Politis; Alessandro Tessitore; Christine Ghadery; Simon Lewis Journal: Mov Disord Clin Pract Date: 2018-10-09
Authors: Marco Godi; Marica Giardini; Antonio Nardone; Anna Maria Turcato; Marco Caligari; Fabrizio Pisano; Marco Schieppati Journal: Front Neurol Date: 2017-02-28 Impact factor: 4.003